Citations for
1DDX43
DDX43 promoter is frequently hypomethylated and may predict a favorable outcome in acute myeloid leukemia.
Lin J, Chen Q, Yang J, Qian J, Deng ZQ, Qian W, Chen XX, Ma JC, Xiong DS, Ma YJ, An C, Tang CY.
Leuk Res 38(5):601-7. doi: 10.1016/j.leukres.2014.02.012. Epub 2014 Mar 3. 2014
2DDX43
The methylation status of the DDX43 promoter in Chinese patients with chronic myeloid leukemia.
Chen Q, Lin J, Qian J, Deng ZQ, Qian W, Yang J, Li Y, Chen XX, Ma YJ, Ma JC, Liu Q.
Genet Test Mol Biomarkers 17(6):508-11. doi: 10.1089/gtmb.2012.0530. Epub 2013 Mar 15. 2013
3DDX43
The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo.
Linley AJ, Mathieu MG, Miles AK, Rees RC, McArdle SE, Regad T.
J Biol Chem 287(17):13633-43. doi: 10.1074/jbc.M111.308973. Epub 2012 Mar 5. 2012
4DDX43
HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancers.
Mathieu MG, Linley AJ, Reeder SP, Badoual C, Tartour E, Rees RC, McArdle SE.
Cancer Immun 10:2. 2010
5DDX43
Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia.
Roman-Gomez J, Jimenez-Velasco A, Agirre X, Castillejo JA, Navarro G, San Jose-Eneriz E, Garate L, Cordeu L, Cervantes F, Prosper F, Heiniger A, Torres A.
Haematologica 92(2):153-62. 2007
6DDX23, DDX27, DDX31, DDX41, DDX42, DDX43, DDX46, DDX47, DDX49, DDX50, DDX51, DDX52, DDX53, DDX54, DDX55, DDX56, DHX15, DHX29, DHX30, DHX32, DHX33, DHX34, DHX35, DHX36, DHX37, DHX38, DHX40, DHX57, DHX8, DHX9, EIF4A2, EIF4A3
The human DDX and DHX gene families of putative RNA helicases.
Abdelhaleem M, Maltais L, Wain H.
Genomics 81(6):618-22. 2003
7DDX43
Frequent expression of HAGE in presentation chronic myeloid leukaemias.
Adams SP, Sahota SS, Mijovic A, Czepulkowski B, Padua RA, Mufti GJ, Guinn BA.
Leukemia 16(11):2238-42. 2002
8DDX43, SAGE1
Identification on a human sarcoma of two new genes with tumor-specific expression.
Martelange V, De Smet C, De Plaen E, Lurquin C, Boon T.
Cancer Res 60(14):3848-55. 2000